NEA Management Company’s Addex Therapeutics ADXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-9,000
| Closed | -$306K | – | 46 |
|
|
2023
Q4 | $306K | Hold |
9,000
| – | – | 0.02% | 44 |
|
|
2023
Q3 | $408K | Hold |
9,000
| – | – | 0.03% | 43 |
|
|
2023
Q2 | $633K | Sell |
9,000
-273,435
| -97% | -$19.2M | 0.05% | 42 |
|
|
2023
Q1 | $1.11M | Buy |
282,435
+228,435
| +423% | +$900K | 0.08% | 43 |
|
|
2022
Q4 | $113K | Sell |
54,000
-228,435
| -81% | -$480K | 0.01% | 54 |
|
|
2022
Q3 | $830K | Buy |
282,435
+235,363
| +500% | +$692K | 0.04% | 53 |
|
|
2022
Q2 | $1.08M | Buy |
47,072
+38,072
| +423% | +$876K | 0.06% | 54 |
|
|
2022
Q1 | $914K | Hold |
9,000
| – | – | 0.03% | 55 |
|
|
2021
Q4 | $205K | Hold |
9,000
| – | – | ﹤0.01% | 58 |
|
|
2021
Q3 | $1.62M | Hold |
9,000
| – | – | 0.02% | 60 |
|
|
2021
Q2 | $17.2M | Buy |
+9,000
| New | +$17.2M | 0.22% | 46 |
|